Login
Home
Charts
Search
Watchlist
Products

Astec Lifesciences Ltd

ASTEC·NSE
₹792.80+10.20%Tue, 22 Sept '26 15:22
Industry:Pesticides/Agrochemicals
Indices:

Astec Lifesciences Ltd

ASTEC
NSE
₹792.80
+10.20%
|Tue, 22 Sept '26 15:22
SOICxStockScans Reports
Industry
Pesticides/Agrochemicals
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,767Cr
Close
Close Price
₹793.05
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
—
PS
Price To Sales
4.01
Revenue
Revenue
₹441Cr
Rev Gr TTM
Revenue Growth TTM
9.33%
PAT Gr TTM
PAT Growth TTM
48.00%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
11151154699994120917412515984
Growth YoY
Revenue Growth YoY%
-44.5-56.721.1-51.4-11.184.8-22.331.3-25.232.932.7-8.3
Expenses
ExpensesCr
114691411161181001141028012114984
Operating Profit
Operating ProfitCr
-3-1813-46-20-66-11-749-1
OPM
OPM%
-3.1-36.18.3-66.7-20.0-6.14.6-12.1-9.13.25.8-0.8
Other Income
Other IncomeCr
112122111-131
Interest Expense
Interest ExpenseCr
667791010118788
Depreciation
DepreciationCr
99991111121110111211
PBT
PBTCr
-18-32-1-62-39-25-16-33-24-16-8-19
Tax
TaxCr
-4-80-22015000000
PAT
PATCr
-13-24-1-40-39-40-16-33-24-16-8-19
Growth YoY
PAT Growth YoY%
-173.3-2,962.380.7-385.0-187.3-65.9-1,575.016.836.661.151.843.4
NPM
NPM%
-12.1-47.9-0.6-57.3-39.1-43.0-13.4-36.3-33.1-12.6-4.9-22.4
EPS
EPS₹
-6.8-12.3-0.5-20.1-19.5-20.4-8.1-16.7-11.3-7.0-3.5-8.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
11151154699994120917412515984
Growth YoY
Revenue Growth YoY%
-44.5-56.721.1-51.4-11.184.8-22.331.3-25.232.932.7-8.3
Expenses
ExpensesCr
114691411161181001141028012114984
Operating Profit
Operating ProfitCr
-3-1813-46-20-66-11-749-1
OPM
OPM%
-3.1-36.18.3-66.7-20.0-6.14.6-12.1-9.13.25.8-0.8
Other Income
Other IncomeCr
112122111-131
Interest Expense
Interest ExpenseCr
667791010118788
Depreciation
DepreciationCr
99991111121110111211
PBT
PBTCr
-18-32-1-62-39-25-16-33-24-16-8-19
Tax
TaxCr
-4-80-22015000000
PAT
PATCr
-13-24-1-40-39-40-16-33-24-16-8-19
Growth YoY
PAT Growth YoY%
-173.3-2,962.380.7-385.0-187.3-65.9-1,575.016.836.661.151.843.4
NPM
NPM%
-12.1-47.9-0.6-57.3-39.1-43.0-13.4-36.3-33.1-12.6-4.9-22.4
EPS
EPS₹
-6.8-12.3-0.5-20.1-19.5-20.4-8.1-16.7-11.3-7.0-3.5-8.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
233299368431523555677628458381448441
Growth
Revenue Growth%
-12.728.223.117.221.36.221.9-7.2-27.1-16.817.59.3
Expenses
ExpensesCr
201236299354437443522552464448453435
Operating Profit
Operating ProfitCr
326269768511215476-6-66-56
OPM
OPM%
13.620.918.717.816.320.122.812.1-1.3-17.4-1.01.3
Other Income
Other IncomeCr
4-8121112810136633
Interest Expense
Interest ExpenseCr
1312111213592125373531
Depreciation
DepreciationCr
101415192326343436444545
PBT
PBTCr
12295656618912135-62-141-81-67
Tax
TaxCr
71021201424319-15-600
PAT
PATCr
519353648659026-47-135-81-67
Growth
PAT Growth%
-65.7278.682.72.132.936.938.1-71.5-283.2-187.340.048.0
NPM
NPM%
2.26.49.58.39.111.713.34.1-10.2-35.3-18.1-15.1
EPS
EPS₹
2.59.717.818.124.133.045.512.9-23.8-68.2-37.8-30.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
233299368431523555677628458381448441
Growth
Revenue Growth%
-12.728.223.117.221.36.221.9-7.2-27.1-16.817.59.3
Expenses
ExpensesCr
201236299354437443522552464448453435
Operating Profit
Operating ProfitCr
326269768511215476-6-66-56
OPM
OPM%
13.620.918.717.816.320.122.812.1-1.3-17.4-1.01.3
Other Income
Other IncomeCr
4-8121112810136633
Interest Expense
Interest ExpenseCr
1312111213592125373531
Depreciation
DepreciationCr
101415192326343436444545
PBT
PBTCr
12295656618912135-62-141-81-67
Tax
TaxCr
71021201424319-15-600
PAT
PATCr
519353648659026-47-135-81-67
Growth
PAT Growth%
-65.7278.682.72.132.936.938.1-71.5-283.2-187.340.048.0
NPM
NPM%
2.26.49.58.39.111.713.34.1-10.2-35.3-18.1-15.1
EPS
EPS₹
2.59.717.818.124.133.045.512.9-23.8-68.2-37.8-30.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
19,45,50620202020202020202022
Reserves
ReservesCr
99119150183227290377400350215368
Current Liabilities
Current LiabilitiesCr
203194238249318322491526397366500
Non Current Liabilities
Non Current LiabilitiesCr
9259646103420828151
Total Liabilities
Total LiabilitiesCr
330334413461572678897979975881942
Current Assets
Current AssetsCr
191198232248332330516499398341443
Non Current Assets
Non Current AssetsCr
139135182213240347381481576540499
Total Assets
Total AssetsCr
330334413461572678897979975881942
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
19,45,50620202020202020202022
Reserves
ReservesCr
99119150183227290377400350215368
Current Liabilities
Current LiabilitiesCr
203194238249318322491526397366500
Non Current Liabilities
Non Current LiabilitiesCr
9259646103420828151
Total Liabilities
Total LiabilitiesCr
330334413461572678897979975881942
Current Assets
Current AssetsCr
191198232248332330516499398341443
Non Current Assets
Non Current AssetsCr
139135182213240347381481576540499
Total Assets
Total AssetsCr
330334413461572678897979975881942

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13196515168-8247510-8-81
Investing Cash Flow
Investing Cash FlowCr
-16-18-49-53-74-73-104-113-135-15-4
Financing Cash Flow
Financing Cash FlowCr
31-1-1837-958180381252494
Net Cash Flow
Net Cash FlowCr
21-300000009
Free Cash Flow
Free Cash FlowCr
-39-115-37123-111-80-42-125-24-86
CFO To PAT
CFO To PAT%
-247.4100.3184.642.7354.4-12.526.3291.7-21.86.299.8
CFO To EBITDA
CFO To EBITDA%
-39.730.894.020.0197.8-7.315.397.9-172.912.71,783.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13196515168-8247510-8-81
Investing Cash Flow
Investing Cash FlowCr
-16-18-49-53-74-73-104-113-135-15-4
Financing Cash Flow
Financing Cash FlowCr
31-1-1837-958180381252494
Net Cash Flow
Net Cash FlowCr
21-300000009
Free Cash Flow
Free Cash FlowCr
-39-115-37123-111-80-42-125-24-86
CFO To PAT
CFO To PAT%
-247.4100.3184.642.7354.4-12.526.3291.7-21.86.299.8
CFO To EBITDA
CFO To EBITDA%
-39.730.894.020.0197.8-7.315.397.9-172.912.71,783.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3791,1781,1361,0537831,9593,4342,7102,0831,3231,2021,767
Price To Earnings
Price To Earnings
76.561.632.529.516.530.138.2106.0
Price To Sales
Price To Sales
1.63.93.12.41.53.55.14.34.53.52.74.0
Price To Book
Price To Book
3.28.56.75.23.26.38.76.55.65.63.14.5
EV To EBITDA
EV To EBITDA
15.520.818.316.110.319.224.140.0-435.4-28.3-362.0355.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.833.229.828.428.731.735.226.219.07.320.120.1
OPM
OPM%
13.620.918.717.816.320.122.812.1-1.3-17.4-1.01.3
NPM
NPM%
2.26.49.58.39.111.713.34.1-10.2-35.3-18.1-15.1
ROCE
ROCE%
0.015.522.618.121.418.919.37.3-4.2-13.2-5.5-5.5
ROE
ROE%
0.013.920.617.719.321.122.76.1-12.7-57.4-20.7-20.7
ROA
ROA%
1.55.88.57.88.39.610.02.6-4.8-15.3-8.6-8.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3791,1781,1361,0537831,9593,4342,7102,0831,3231,2021,767
Price To Earnings
Price To Earnings
76.561.632.529.516.530.138.2106.0
Price To Sales
Price To Sales
1.63.93.12.41.53.55.14.34.53.52.74.0
Price To Book
Price To Book
3.28.56.75.23.26.38.76.55.65.63.14.5
EV To EBITDA
EV To EBITDA
15.520.818.316.110.319.224.140.0-435.4-28.3-362.0355.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.833.229.828.428.731.735.226.219.07.320.120.1
OPM
OPM%
13.620.918.717.816.320.122.812.1-1.3-17.4-1.01.3
NPM
NPM%
2.26.49.58.39.111.713.34.1-10.2-35.3-18.1-15.1
ROCE
ROCE%
0.015.522.618.121.418.919.37.3-4.2-13.2-5.5-5.5
ROE
ROE%
0.013.920.617.719.321.122.76.1-12.7-57.4-20.7-20.7
ROA
ROA%
1.55.88.57.88.39.610.02.6-4.8-15.3-8.6-8.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Astec Lifesciences Ltd

  • Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/a2vkcoicde9v7nii4gvnjuwy.pdf
  • Q4 FY2022 Earnings Call Transcript (Mar 2022, PDF): https://www.stockscans.in/document/z1joyl0xfcggv7rs3utcdug2.pdf
  • Q2 FY2022 Earnings Call Transcript (Sep 2021, PDF): https://www.stockscans.in/document/ks6250m9n9pqonr8l6ln777l.pdf
  • Q1 FY2022 Earnings Call Transcript (Jun 2021, PDF): https://www.stockscans.in/document/5nxeueklin1dwxa8ur082w6a.pdf
  • Q4 FY2021 Earnings Call Transcript (Mar 2021, PDF): https://www.stockscans.in/document/k8fm39v2x83a27r8prqh8isn.pdf
  • Q3 FY2021 Earnings Call Transcript (Dec 2020, PDF): https://www.stockscans.in/document/i4ukmio40nf49voqwet3kos5.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/i9vzxj675i06gi61ugd9sfp1.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/hq18e1hl1abkttry8dqwtcoo.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/4mqtvadzyvr2i4x9efb8bk1p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/tf6y04cpjntsgwkd9m8ndf6a.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ju60fqyxe8lgxjstcuyuqeyj.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/pldjhe4chxgc9zi0iqhuj8jv.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/7445ul5860pwb9xbw47wxdmx.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/lpoeit308dvoxflx5er58rr4.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ofyfe1gteq3j5gec9xszekd8.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/2d8epwps9yhy88yn3u6kmhli.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/2chn3asyhdnhts82wh626a3a.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/azej6b4bnj1oyvdy0yqkkxf2.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/gsafhksv18xefat4606edocy.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/dmr1sm8gvi3dwzdkpjasfptj.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/aihe98kcg2h0idche6uz08a8.pdf

Concall Transcript Summaries — Astec Lifesciences Ltd

  • Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/NSE%3AASTEC/transcript-notes/202209/a2vkcoicde9v7nii4gvnjuwy.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies